Clinical trial · Observational
Clinical Evaluation of Fenestration Decompression Combined With Secondary Curettage for Ameloblastoma of the Jaw: Retrospective Radiographic Analysis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Objectives: To investigate the outcomes of fenestration decompression combined with secondary curettage (FDSC) in the surgical treatment of jaw ameloblastoma. Methods: Medical records of patients diagnosed as multicystic ameloblastoma (MA) or unicystic ameloblastoma (UA) by routine pathology were collected from January 2010 to December 2017 in Ninth People's Hospital, Shanghai JiaoTong University Medical College. Patients were divided into two groups based on the management regimen: FDSC group, and local curettage (LC) group. Patients were followed up for 3-8 years, using panoramic radiography to measure the change of the area of the cystic cavity involved in ameloblastoma and the recurrence or malignant transformation of the tumor in both groups. A total of 233 eligible patients were selected for provisional screening, including 145 patients with MA, and 88 patients with UA.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cystic Cavity Area Reduction Efficiency | — | UNRESOLVED | — |
| the Recurrence of the Tumor | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| fenestration decompression combined with secondary curettage | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Fenestration decompression combined with secondary curettage (FDSC)
- description
- Design of the opening window reasonably；Making cyst plug；secondary curettage
- interventionNames
- Procedure: fenestration decompression combined with secondary curettage
- label
- local curettage (LC)
- description
- The tumor was removed by local curettage only
Primary outcomes (1)
- measure
- Cystic cavity area reduction efficiency
- timeFrame
- 3 years after surgery
- description
- (good effect case number + moderate effect case number)/total case number
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: -Medical records of patients who were diagnosed with multicystic ameloblastoma (MA) or unicystic ameloblastoma (UA) by routine pathology were collected from January 2010 to December 2017 in Ninth People's Hospital of Shanghai JiaoTong University Medical College. Exclusion Criteria: * followed up less than 3 years * For FDSC group, fenestration decompression failed * recurrent ameloblastoma * received other type of surgery;
References
Publications (0)
Data not yet available